Testimony before the House Energy & Commerce Subcommittee: “Opportunities to Improve the 340B Drug Pricing Program”

Statement of the American Hospital Association for the Energy and Commerce Subcommittee on Health of the U.S. House of Representatives for the July 11, 2018 hearing on “Opportunities to Improve the 340B Drug Pricing Program”

On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – the American Hospital Association (AHA) appreciates the opportunity to express our strong support for the 340B program.

Read the full statement below.

Related Resources

Guides/Reports
Tax-exempt hospitals are required to publicly report on the ways in which they improve the health of the communities they serve yearly through the IRS Form 990…
Fact Sheets
Public
The COVID-19 pandemic has altered hospitals’ payer mix, which for some hospitals has temporarily lowered their disproportionate share hospital (DSH) percentage…
Fact Sheets
It is imperative that Congress invest in America’s hospitals and health systems to ensure that the nation’s health care needs can be met today and into the…
Letter/Comment
The American Hospital Association (AHA) would like to share hospital and health system priorities that would benefit patients and communities around the…
Special Bulletin
Public
Download the AHA Special Bulletin: CMS Issues Hospital Outpatient/ASC Proposed Rule, Including Modifications to Price Transparency Rule
Special Bulletin
Public
President Biden today signed an executive order (EO) establishing a “whole-of-government” effort to promote competition in the American economy. The EO…